Nagler A - Search Results

1

Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood.

Condiotti R, Zakai YB, Barak V, Nagler A. Condiotti R, et al. Among authors: nagler a. Exp Hematol. 2001 Jan;29(1):104-13. doi: 10.1016/s0301-472x(00)00617-2. Exp Hematol. 2001. PMID: 11164111 Free article.

2

Effect of bone marrow T lymphocytes treated with CAMPATH 1G on megakaryocyte colony formation.

Deutsch VR, Nagler A, Slavin S, Condiotti R, Levine RF, Eldor A. Deutsch VR, et al. Among authors: nagler a. Exp Hematol. 1993 Oct;21(11):1427-35. Exp Hematol. 1993. PMID: 8405223

3

The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).

Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A. Bishara A, et al. Among authors: nagler a. Exp Hematol. 1995 Dec;23(14):1667-75. Exp Hematol. 1995. PMID: 8542963

4

ASTA-Z 7557 impairs human natural killer (NK) cell activity.

Condiotti R, Slavin S, Nagler A. Condiotti R, et al. Among authors: nagler a. Leuk Res. 1996 Feb;20(2):169-74. doi: 10.1016/0145-2126(95)00142-5. Leuk Res. 1996. PMID: 8628016

5

The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors.

Condiotti R, Slavin S, Barak V, Nagler A. Condiotti R, et al. Among authors: nagler a. Leuk Res. 1996 Jan;20(1):57-63. doi: 10.1016/0145-2126(95)00110-7. Leuk Res. 1996. PMID: 8632678

6

Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity.

Condiotti R, Nagler A. Condiotti R, et al. Among authors: nagler a. Bone Marrow Transplant. 1996 Oct;18(4):713-20. Bone Marrow Transplant. 1996. PMID: 8899185

7

Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.

Levi-Schaffer F, Segal V, Barak V, Rubinchik E, Nagler A. Levi-Schaffer F, et al. Among authors: nagler a. Exp Hematol. 1997 Mar;25(3):238-45. Exp Hematol. 1997. PMID: 9091300

8

Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.

Condiotti R, Nagler A. Condiotti R, et al. Among authors: nagler a. Exp Hematol. 1998 Jul;26(7):571-9. Exp Hematol. 1998. PMID: 9657131

9

Cytokine dysregulation in chronic graft versus host disease.

Barak V, Levi-Schaffer F, Nisman B, Nagler A. Barak V, et al. Among authors: nagler a. Leuk Lymphoma. 1995 Mar;17(1-2):169-73. doi: 10.3109/10428199509051718. Leuk Lymphoma. 1995. PMID: 7773155

10

Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2a.

Nagler A, Ackerstein A, Barak V, Slavin S. Nagler A, et al. J Hematother. 1994 Spring;3(1):75-82. doi: 10.1089/scd.1.1994.3.75. J Hematother. 1994. PMID: 7922012 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,464 results

Search Page

Filters